Skip to main content
Medical information Clinical review pending

Genetic Testing

GATA2 Full Length Gene Sequencing for Chronic Neutropenia, MonoMac Syndrome, Mylodysplasia, and AML

GATA2 Full Length Gene Sequencing helps diagnose conditions like Chronic Neutropenia, MonoMac Syndrome, Mylodysplasia, and AML by identifying mutations in the GATA2 gene.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
Bone marrow or peripheral blood collected in an EDTA Vacutainer tube (2ml).
Results
Confirm with the laboratory before booking.
Preparation
Confirm with the laboratory before booking. A Doctor’s prescription is required prior to testing, unless for surgery, pregnancy, or planned travel abroad.
Test priceKSh 48,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the GATA2 Full Length Gene Sequencing for Chronic Neutropenia, MonoMac Syndrome, Mylodysplasia, and AML test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Recurrent infections
  • ✓Low blood cell counts (neutropenia, monocytopenia)
  • ✓Suspected Myelodysplasia
  • ✓Suspected Acute Myeloid Leukemia (AML)
  • ✓Family history of related blood disorders
  • ✓Diagnosis of MonoMac Syndrome
02

In plain language

What this test helps you understand

Identifies mutations in the GATA2 gene associated with Chronic Neutropenia, MonoMac Syndrome, Myelodysplasia, and AML, aiding in diagnosis and guiding treatment strategies.
The GATA2 Full Length Gene Sequencing test is a specialized genetic analysis used to help diagnose several serious blood-related conditions, including Chronic Neutropenia, MonoMac Syndrome, Myelodysplasia, and Acute Myeloid Leukemia (AML). This test examines the GATA2 gene, which plays a crucial role in the development and function of blood cells. Identifying genetic changes in this gene can provide valuable information for diagnosis and treatment planning.

This test specifically looks for mutations or alterations within the GATA2 gene. Detecting these changes helps healthcare providers understand the underlying genetic causes of a patient's symptoms, leading to more precise diagnoses and tailored treatment approaches.

Individuals experiencing symptoms like frequent infections, low blood cell counts, or unexplained bleeding may be candidates for this test. It may also be recommended for those with a family history of blood disorders or related genetic conditions.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationConfirm with the laboratory before booking. A Doctor’s prescription is required prior to testing, unless for surgery, pregnancy, or planned travel abroad.
SampleBone marrow or peripheral blood collected in an EDTA Vacutainer tube (2ml).
MethodologyGene sequencing analysis of the GATA2 gene.
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
This test analyzes the GATA2 gene specifically. It may not detect mutations in other genes associated with similar conditions. Results must be interpreted in the context of clinical findings and other laboratory tests. Confirm with the laboratory before booking.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

This test helps diagnose Chronic Neutropenia, MonoMac Syndrome, Myelodysplasia, and Acute Myeloid Leukemia (AML).
The GATA2 gene provides instructions for making a protein that is important for the development and function of blood cells.
Individuals with symptoms like recurrent infections, low blood cell counts, or a family history of related blood disorders should discuss this test with their doctor.
A sample of bone marrow or peripheral blood is required for this test.
Confirm with the laboratory before booking for the current turnaround time.
Yes, a doctor's prescription is required before testing, except in specific circumstances like surgery, pregnancy, or planned travel abroad.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp